Outlook: The Neuroscience Issue
Already one of the world’s premier institutions in neuroscience research, WashU Medicine is deepening its investment. Read about our approach, areas of focus and latest advances in Outlook Winter 2023-24.
Lowering a form of brain cholesterol reduces Alzheimer’s-like damage in mice (Links to an external site)
Targeting cholesterol potentially could help treat Alzheimer’s, related dementias
Ashrafi receives Ben Barres Early Career Acceleration Award (Links to an external site)
Grant to support research on neurodegenerative disorders
Device for noninvasive brain biopsies via blood draw moves closer to market approval (Links to an external site)
FDA grants WashU-based technology ‘Breakthrough Device’ designation
Tuberous Sclerosis Center expands with addition of Adult TSC Director Nascimento (Links to an external site)
The center, which focuses on multidisciplinary patient care and research, is one of only 13 TSC Centers of Excellence nationwide.
Anesthesiologist volunteers with group that treats Ukrainian pediatric burn patients (Links to an external site)
Knittel works with the group Doctors Collaborating to Help Children
Biotech industry leader to helm WashU drug development accelerator (Links to an external site)
Bhagwat leads program aimed at moving promising therapeutics into clinical trials
Baldridge receives Avenir Award for early-career scientists (Links to an external site)
Grant to support research on genetics of substance use disorders
Fagan receives lifetime achievement award from Alzheimer’s Association (Links to an external site)
Recognized for work on fluid biomarkers for Alzheimer’s
Avidan, England, Miller elected to National Academy of Medicine (Links to an external site)
Membership is one of highest U.S. honors in health and medicine
Liquid biopsy could guide treatment decisions for oligometastatic lung cancer (Links to an external site)
Blood test to detect tumor DNA could help decide between radiation, chemotherapy